(Reuters) -A state judge in Oregon has overturned a jury's $260 million verdict against Johnson & Johnson in a lawsuit brought by a woman who said she got mesothelioma, a deadly cancer linked to ...

A court tossed out a $223 million jury award to four plaintiffs who claimed they developed cancer from using Johnson & Johnson's baby powder.

Dallas-based Dean Omar Branham Shirley is handling another talcum powder trial against Johnson & Johnson, which began on ...

The ruling comes as J&J is gearing up to face a spate of jury trials early next year over allegations its executives knew since the early 1970s their talc contained trace amounts of asbestos, but ...

Johnson & Johnson JNJ announced that a bankruptcy court in Texas has rejected its bankruptcy plan to resolve talc lawsuits for the third time. J&J faces more than 62,000 lawsuits for its talc ...

The verdict was awarded to Janice Paluzzi, an 84-year-old Massachusetts woman who developed mesothelioma, a rare and aggressive cancer linked to asbestos exposure.

Some legal experts say Tuesday's verdict could make it harder for Johnson & Johnson to finalize its proposed $8.9 billion settlement in the Chapter 11 talc case.

J&J wants to use Chapter 11 proceedings because bankruptcy judges can enforce global settlements that permanently halt all related lawsuits and forbid new ones, all for a capped payout.

J&J has maintained that its now-discontinued talc products are safe and do not cause cancer. It previously set aside $400 million to resolve state claims.

J&J is liable for Valadez’s economic damages of $3.8 million and his noneconomic damages of $15 million, according to the verdict.

Johnson & Johnson (NYSE:JNJ) is one of the 10 undervalued blue chip stocks analysts recommend for smart investing. On June 18, Dean Omar Branham Shirley, LLP, a Dallas, Texas-based law firm ...